UNI-EN 24:Notification for a technical mistake concerning the second date for the AGM
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
-
Notification OSA ENG.doc
Notification for a technical mistake concerning the second date for the AGM
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 24 | / | 2017 | |||||||
| Date of issue: | 2017-05-02 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification for a technical mistake concerning the second date for the AGM | |||||||||||
| Official market - legal basis | |||||||||||
| art. 17. 1 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Dear Shareholders, Тhe invitation for the Annual General Meeting of shareholders of Sopharma AD convened for 2 June, 2017 published in x3news, investor.bg and the website of the company www.sopharmagroup.bg contains a technical mistake concerning the second date for the AGM, which is announced in case of lack of quorum on 2 June 2017: In the first paragraph of the invitation the listed second date is 16 July 2017 and in the last paragraph the listed second date is 16 June 2017. We would hereby like to advise all shareholders that the correct second date under the conditions of art. 227, para 3 of the Commercial code for the Annual General Meeting of shareholders of Sopharma AD is 16 June 2017. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Notification OSA ENG.doc Notification OSA ENG.doc | Notification for a technical mistake concerning the second date for the AGM | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2017-05-02 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 7.31 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
